JP2011511776A5 - - Google Patents

Download PDF

Info

Publication number
JP2011511776A5
JP2011511776A5 JP2010544836A JP2010544836A JP2011511776A5 JP 2011511776 A5 JP2011511776 A5 JP 2011511776A5 JP 2010544836 A JP2010544836 A JP 2010544836A JP 2010544836 A JP2010544836 A JP 2010544836A JP 2011511776 A5 JP2011511776 A5 JP 2011511776A5
Authority
JP
Japan
Prior art keywords
sirna
spermine
luciferase
interferin
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010544836A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011511776A (ja
Filing date
Publication date
Priority claimed from FR0800492A external-priority patent/FR2926818B1/fr
Application filed filed Critical
Publication of JP2011511776A publication Critical patent/JP2011511776A/ja
Publication of JP2011511776A5 publication Critical patent/JP2011511776A5/ja
Pending legal-status Critical Current

Links

JP2010544836A 2008-01-30 2009-01-30 RNA干渉のためのカチオン性siRNA、合成及び使用 Pending JP2011511776A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0800492A FR2926818B1 (fr) 2008-01-30 2008-01-30 siRNA CATIONIQUES, SYNTHESE ET UTILISATION POUR L'ARN INTERFERENCE
PCT/IB2009/050379 WO2009095887A1 (fr) 2008-01-30 2009-01-30 siRNA CATIONIQUES, SYNTHÈSE ET UTILISATION POUR L'ARN INTERFÉRENCE

Publications (2)

Publication Number Publication Date
JP2011511776A JP2011511776A (ja) 2011-04-14
JP2011511776A5 true JP2011511776A5 (enExample) 2011-12-15

Family

ID=39683957

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010544836A Pending JP2011511776A (ja) 2008-01-30 2009-01-30 RNA干渉のためのカチオン性siRNA、合成及び使用

Country Status (13)

Country Link
US (1) US10927371B2 (enExample)
EP (1) EP2250267B1 (enExample)
JP (1) JP2011511776A (enExample)
KR (1) KR20100120293A (enExample)
CN (1) CN101960009A (enExample)
AU (1) AU2009208646A1 (enExample)
BR (1) BRPI0907494A2 (enExample)
CA (1) CA2713075A1 (enExample)
FR (1) FR2926818B1 (enExample)
IL (1) IL207290A0 (enExample)
NZ (1) NZ587117A (enExample)
RU (1) RU2010136047A (enExample)
WO (1) WO2009095887A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006325054B2 (en) * 2005-12-15 2013-05-02 Centre National De La Recherche Scientifique (Cnrs) Cationic oligonucleotides, automated methods for preparing same and their uses
WO2015015498A1 (en) * 2013-07-31 2015-02-05 Qbi Enterprises Ltd. Methods of use of sphingolipid polyalkylamine oligonucleotide compounds
AU2016226418B2 (en) 2015-03-02 2022-05-26 Synthetic Genomics, Inc. Regulatory elements from labyrinthulomycetes microorganisms
US10633454B2 (en) 2016-11-01 2020-04-28 Conagen Inc. Expression of modified glycoproteins and glycopeptides
EP3535385A4 (en) * 2016-11-01 2020-06-17 Conagen Inc. EXPRESSION OF MODIFIED GLYCOPROTEINS AND GLYCOPEPTIDES
CN106498072B (zh) * 2016-11-24 2019-09-10 青岛千卓分子生物科技有限公司 一种液态产品中外源dna内标物的保护方法及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071890A (en) 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
EP1013770A1 (en) 1998-12-23 2000-06-28 Université Louis Pasteur de Strasbourg Non-viral transfection vector
DE10207177A1 (de) 2002-02-19 2003-09-04 Novosom Ag Fakultativ kationische Lipide
US20040019008A1 (en) 2002-05-28 2004-01-29 Lewis David L. Compositions and processes using siRNA, amphipathic compounds and polycations
JP2004137143A (ja) 2002-08-21 2004-05-13 Fuji Photo Film Co Ltd 有機変性層状珪酸塩及びその組成物
EP1585756B1 (en) * 2002-11-26 2010-04-21 University of Massachusetts Delivery of sirnas
EP1638919B1 (en) * 2003-06-18 2012-09-26 Biolab Ltd. Sphingolipids polyalkylamines conjugates
WO2005060697A2 (en) * 2003-12-19 2005-07-07 Chiron Corporation Cell transfecting formulations of small interfering rna, related compositions and methods of making and use
US20060073505A1 (en) * 2004-09-21 2006-04-06 Isis Pharmaceuticals, Inc. Oligomeric compounds effecting drosha-mediated cleavage
JP2008519053A (ja) * 2004-11-04 2008-06-05 アンディーノ,ラウル 小さい干渉RNA(siRNA)のポリアミン共役体の合成及びそれによって形成された共役体
CA2587962A1 (en) * 2004-11-17 2006-06-08 University Of Maryland, Baltimore Highly branched hk peptides as effective carriers of sirna
AU2006325054B2 (en) 2005-12-15 2013-05-02 Centre National De La Recherche Scientifique (Cnrs) Cationic oligonucleotides, automated methods for preparing same and their uses
EP1844772A1 (en) 2006-04-06 2007-10-17 Polyplus-Transfection SA Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications
EP2992875A1 (en) * 2006-04-20 2016-03-09 Silence Therapeutics GmbH Lipoplex formulations for specific delivery to vascular endothelium

Similar Documents

Publication Publication Date Title
JP2011511776A5 (enExample)
Troiber et al. Stabilizing effect of tyrosine trimers on pDNA and siRNA polyplexes
EP3610884B1 (en) Peptide containing conjugates for dual molecular delivery of oligonucleotides
Qian et al. Protecting microRNAs from RNase degradation with steric DNA nanostructures
Kumar et al. Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis
EP3756690A3 (en) Membrane-penetrating peptides to enhance transfection and compositions and methods for using same
WO2012149376A3 (en) Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
WO2013056132A3 (en) Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof
ES2676600T3 (es) Fabricación y uso de ARN monocatenario sintetizado in vitro para la introducción en células de mamífero para inducir un efecto biológico o bioquímico
JP2021525508A (ja) 核酸治療薬のための調節可能な共カップリングポリペプチドナノ粒子送達系の組成物および方法
Kozhikhova et al. A novel peptide dendrimer LTP efficiently facilitates transfection of mammalian cells
Kim et al. A self-assembled DNA tetrahedron as a carrier for in vivo liver-specific delivery of siRNA
AU2015302873A1 (en) Compositions and methods for therapeutics prescreening
RU2014110901A (ru) Пептидные частицы и их применение
WO2020020857A1 (en) Fibroadipogenic progenitor-derived exosomes for regeneration of dystrophic muscles
WO2005079532A3 (en) Methods and compositions for enhancing risc activity in vitro and in vivo
Itakura et al. Effective cytoplasmic release of siRNA from liposomal carriers by controlling the electrostatic interaction of siRNA with a charge-invertible peptide, in response to cytoplasmic pH
US20170189441A1 (en) Dual molecular delivery of oligonucleotides and peptide containing conjugates
Hardie et al. Simultaneous cytosolic delivery of a chemotherapeutic and siRNA using nanoparticle-stabilized nanocapsules
Lei et al. Exosome-like vesicles encapsulated with specific microRNAs accelerate burn wound healing and ameliorate scarring
CN103977423B (zh) 一种三角板形核酸纳米制剂及制备方法和应用
US11434317B2 (en) Lipid-polymer based complexation and delivery of nucleic acids
ES2386855T3 (es) Emulación de estructuras de lipoproteínas
Yu et al. Surface charge inversion of self-assembled monolayers by visible light irradiation: cargo loading and release by photoreactions
Zhang et al. Investigation of the electrochemical interaction behavior of DNA with 5-fluorouracil derivatives